PRIA Logo™
HR6320119th CongressWALLET

Improving Medicaid Precision and Cancer Test Act of 2025

Sponsored By: Representative Gottheimer, Josh [D-NJ-5]

Introduced

Summary

This bill would require Medicaid to cover lung cancer biomarker testing nationwide starting January 1, 2027. It adds the test to the list of mandatory Title XIX services so states must include it in their Medicaid plans.

Show full summary
  • Families and patients: Medicaid enrollees diagnosed with lung cancer would have Medicaid-covered biomarker testing beginning January 1, 2027.
  • State Medicaid programs: State plans would be required to add lung cancer biomarker testing to the enumerated mandatory benefits under Title XIX.
  • Clinicians and laboratories: Providers and labs serving Medicaid patients would see coverage of these tests become an explicit federal requirement, supporting billing and access across participating states.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Medicaid would cover lung cancer tests

If enacted, State Medicaid plans would have to cover lung cancer biomarker testing. Coverage would start January 1, 2027. This would help Medicaid enrollees who need this test. The bill text does not specify changes to copays, premiums, or funding.

Sponsors & CoSponsors

Sponsor

Gottheimer, Josh [D-NJ-5]

NJ • D

Cosponsors

  • Rep. Rutherford, John H. [R-FL-5]

    FL • R

    Sponsored 11/28/2025

  • Rep. Swalwell, Eric [D-CA-14]

    CA • D

    Sponsored 12/15/2025

  • Rep. Grijalva, Adelita S. [D-AZ-7]

    AZ • D

    Sponsored 2/3/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation